Long-acting injectable (depot) antipsychotics and changing treatment philosophy: possible contribution to integrative care and personal recovery of schizophrenia

The article disscuses the contribution of LAAIs in the treatment of schizophrenia in comparison with oral equivalents.Given the well-recognized relationship between non-adherence and risk of relapse, patients who are irregular in taking medications are must-offer candidates for LAAIs.